Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Employer Strategies On-Demand Webinars SmithRx Key Takeaways GLP-1s are highly effective for diabetes and obesity but surged demand and costs, use up ~587% and list prices near $1,000/mo, forcing prior auths and spiking employer drug spend
However, the length of time may be adjusted based on how well the treatment works for the individual and whether any side effects are experienced
In our study, PFD did not inhibit fibrosis significantly, which was possibly due to the short duration of the medication (with normal dosing involving 6 weeks of administration in a mouse model and 3-6 months in clinical trials 19,42,43 )
Misconception: GLP-1 medications are just fancy appetite suppressants While appetite suppression is a major component, GLP-1 medications do much more
Over 40 of them are in phase three, meaning well see new things on the market in the next year or two, says Fisher
With over 40 million U.S
